Clinical Trial: A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07424404) titled 'A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively' on Feb. 13.

Brief Summary: The purpose of this study is to evaluate the long-term safety and tolerability of KarXT and KarX-EC for the treatment of Schizophrenia and autism-related irritability in adolescents, respectively

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Schizophrenia Autism-Related Irritability

Intervention: DRUG: KarXT

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Karuna Therapeutic...